Instead, work with your healthcare provider to find legitimate sources or consider approved alternatives in the same medication class
The following protocols represent synthesized guidance from preclinical research, clinical observations, and community experience
The innovative delivery system provides a quick and easy alternative to traditional capsules
Tirzepatide is a dual-acting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
(PubMed) Agarwal A, Vishnu VY, Sharma J, et al
A comprehensive literature search was performed in PubMed, Web of Science, Embase, and Scopus from inception to October 2025 using the keywords tirzepatide, GLP-1/GIP receptor agonist, obstructive sleep apnea, and obesity. Priority was given to randomized controlled trials, major observational studies, and relevant mechanistic research